P. Rolan

788 total citations
14 papers, 619 citations indexed

About

P. Rolan is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, P. Rolan has authored 14 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Molecular Biology. Recurrent topics in P. Rolan's work include Pharmacological Effects and Toxicity Studies (4 papers), Migraine and Headache Studies (3 papers) and Epilepsy research and treatment (3 papers). P. Rolan is often cited by papers focused on Pharmacological Effects and Toxicity Studies (4 papers), Migraine and Headache Studies (3 papers) and Epilepsy research and treatment (3 papers). P. Rolan collaborates with scholars based in United Kingdom, Denmark and France. P. Rolan's co-authors include John Posner, N.T. On, Emma J. Seaber, R Wootton, Steven Phillips, Roopen Arya, A. J. Bellingham, Frank Larsen, John D. Davis and Ivor Benjamin and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Urology and Psychopharmacology.

In The Last Decade

P. Rolan

14 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Rolan United Kingdom 10 189 173 129 114 82 14 619
Emma J. Seaber United Kingdom 8 208 1.1× 146 0.8× 39 0.3× 74 0.6× 36 0.4× 10 509
Helen S. Pentikis United States 14 89 0.5× 109 0.6× 54 0.4× 99 0.9× 76 0.9× 37 557
Dymphy Huntjens Belgium 13 69 0.4× 188 1.1× 58 0.4× 110 1.0× 90 1.1× 28 609
N.T. On United Kingdom 6 110 0.6× 160 0.9× 32 0.2× 81 0.7× 27 0.3× 7 417
Henri Humbert France 15 52 0.3× 173 1.0× 56 0.4× 55 0.5× 71 0.9× 33 590
Stefaan Rossenu Belgium 19 201 1.1× 96 0.6× 75 0.6× 117 1.0× 22 0.3× 35 976
Anne Cooper United Kingdom 13 37 0.2× 169 1.0× 63 0.5× 211 1.9× 69 0.8× 20 724
Heike Lindenmaier Germany 10 77 0.4× 46 0.3× 229 1.8× 397 3.5× 75 0.9× 11 734
T. Pawiński Poland 13 139 0.7× 79 0.5× 146 1.1× 37 0.3× 23 0.3× 45 766
Naotoshi Yamamura Japan 11 51 0.3× 81 0.5× 82 0.6× 116 1.0× 72 0.9× 35 479

Countries citing papers authored by P. Rolan

Since Specialization
Citations

This map shows the geographic impact of P. Rolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Rolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Rolan more than expected).

Fields of papers citing papers by P. Rolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Rolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Rolan. The network helps show where P. Rolan may publish in the future.

Co-authorship network of co-authors of P. Rolan

This figure shows the co-authorship network connecting the top 25 collaborators of P. Rolan. A scholar is included among the top collaborators of P. Rolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Rolan. P. Rolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Marcellin, Patrick, Céline Garret, Valérie Boige, et al.. (2001). Influence of cirrhosis on lamotrigine pharmacokinetics. British Journal of Clinical Pharmacology. 51(5). 410–414. 41 indexed citations
2.
Rolan, P., et al.. (1999). ASSESSMENT OF POTENTIAL EFFECTS OF TAMSULOSIN (OMNIC [R]) ON THE PHARMOCOKINETICS AND PHARMACODYNAMICS OF NICOUMALONE. The Journal of Urology. 235–235. 1 indexed citations
3.
4.
Larsen, Frank, et al.. (1997). Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin. British Journal of Clinical Pharmacology. 44(2). 199–202. 42 indexed citations
5.
Seaber, Emma J., N.T. On, Ruth Dixon, et al.. (1997). The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90). British Journal of Clinical Pharmacology. 43(6). 579–587. 52 indexed citations
6.
Wootton, R, et al.. (1997). Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers. British Journal of Clinical Pharmacology. 43(1). 23–27. 30 indexed citations
7.
Rolan, P., et al.. (1997). Disposition of atovaquone in humans. Antimicrobial Agents and Chemotherapy. 41(6). 1319–1321. 30 indexed citations
8.
Wootton, R, et al.. (1997). Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers. British Journal of Clinical Pharmacology. 43(1). 23–27. 46 indexed citations
9.
Seaber, Emma J., et al.. (1996). The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers. British Journal of Clinical Pharmacology. 41(2). 141–147. 52 indexed citations
10.
Arya, Roopen, et al.. (1996). Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia. British Journal of Haematology. 93(4). 817–821. 41 indexed citations
11.
Pozniak, Anton, et al.. (1996). Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients. Antimicrobial Agents and Chemotherapy. 40(3). 556–560. 25 indexed citations
12.
Danjou, Philippe, et al.. (1995). P-2-106 Evaluation of the potential pharmacokinetic interaction of venlafaxine and carbamazepine. European Neuropsychopharmacology. 5(3). 310–311. 9 indexed citations
13.
Seaber, Emma J., et al.. (1995). Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrobial Agents and Chemotherapy. 39(12). 2759–2764. 239 indexed citations
14.
Rolan, P., et al.. (1990). The onset of effect of the H1-antagonist acrivastine (?Semprex?) assessed by histamine bronchial challenge in volunteers. European Journal of Clinical Pharmacology. 39(3). 311–313. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma J. Seaber Breakdown of academic impact, for papers by Helen S. Pentikis Breakdown of academic impact, for papers by Dymphy Huntjens Breakdown of academic impact, for papers by N.T. On Breakdown of academic impact, for papers by Henri Humbert Breakdown of academic impact, for papers by Stefaan Rossenu Breakdown of academic impact, for papers by Anne Cooper Breakdown of academic impact, for papers by Heike Lindenmaier Breakdown of academic impact, for papers by T. Pawiński Breakdown of academic impact, for papers by Naotoshi Yamamura
Rankless by CCL
2026